Plastics Europe is launching a multimillion-euro, five-year (2022-2026) scientific research project: Brigid. This project aims to assess the potential risks to human health from microplastic exposure through ingestion. Ingestion, along with inhalation, is hypothesised to be the main entrance pathway of microplastics into our bodies.
Microplastic contamination is a global issue, and solutions are urgently needed. Looking forward, it is essential that any measures to tackle the microplastic issue are based on reliable science. However, scientists have not yet fully understood whether microplastic exposure has an effect on humans.
Much research is ongoing, but many of the studies published thus far in the scientific literature have been conducted with unrealistic parameters – for example, a very high concentration of microplastic particles, or particles that are not representative of those commonly found around us.
A five-year (2022-2026) scientific research project
Brigid gets its name from the Celtic Goddess. Part of the Tuatha Dé Danann, the Goddess Brigid is associated with health, protection, and wisdom – three concepts reflected in the core values of project Brigid: gathering knowledge on microplastics, to ultimately protect the health of humans.
These concepts are reflected in the three-armed Brigid’s cross, which has inspired the logo of our initiative – also a nod to the three-tiered experimental approach of cell, tissue, and organism testing.
Brigid will focus on microplastics of seven different polymer types: polyethylene (both linear low density & low/high density), polypropylene, polystyrene, (rigid) polyvinyl chloride, polycarbonate, and polyamide-6. In the absence of robust real-world exposure data, these polymer types are assumed to be the most representative, amongst those produced by our members, of what the average person potentially encounters most often during their daily life.
The structure of Brigid is divided in six interconnected Working Packages (WPs), see below:
|WP1||Here, microplastics will be prepared through the micronisation of commercial polymer grades the seven polymer types. Some microplastics will be labelled, to better track them during exposure experiments. All the WP1 microplastics will be characterised with different analytical techniques.|
|WP2 ||The exposure assessment working package: the objective is to confirm the presence in the body and track the path of microplastics, through different Tasks.|
Task 2.1: a human exposure computer model, built in collaboration with Cefic-LRI project B24.
Task 2.2: cell-culture assays to establish the potential for microplastics to cross biological membranes.
Task 2.3: a study aiming to count and characterise microplastics in human stool.
Task 2.4: studies to track microplastics in model organisms.
|WP3||The hazard assessment working package: we will follow a three-tiered approach of increased complexity, starting with cell cultures, through whole tissues, and finally organisms. The objective is to confirm and quantify if the presence of microplastics in the body poses a hazard to human health.|
|WP4||The risk assessment working package. Data from WP2 and WP3 is fed into this working package: here, an innovative approach to risk assessment will be deployed. It will combine traditional in vivo-based risk assessment with elements from next-generation alternative techniques.|
|WP5||The communication and dissemination working package: We are committed to granting access to our results for everyone. Therefore, project’s findings will be shared with all involved stakeholders. Information will be disseminated, transparently, using language and means that meet the needs of each stakeholder audience depending on their level of technical expertise. |
The administration and project management working package. All the important, if unglamourous, tasks needed to make science happen, fill data gaps, and generate answers to the questions we have on microplastics.
The work within these working packages is performed by a Consortium of independent Partners: internationally known scientists from both private and public research institutes, such as the Wageningen University and Research (WUR) and the Nederlandse Organisatie voor Toegepast Natuurwetenschappelijk Onderzoek (TNO) in the Netherlands. Brigid also has an Advisory Board of 14 independent members, bringing their different backgrounds – science, policy, NGO and governmental agencies – and perspectives together to recommend and advise on further steps.
Actions from the industry
We have been active on the global level to activate microplastic research and coordinate between national and international projects:
Brigid is part of the International Council of Chemical Associations (ICCA) MARII initiative.
Brigid stands as a part of the plan which will bring Plastics Europe’s member companies toward their Safety, Sustainability, and Circularity goals. Our aim is to answer important questions about the potential effect of microplastics on humans, and, in the process, contribute to the development of evidence-based and effective policy making. We are excited to start this research project: stay tuned for the official Brigid Launch in April 2022!
For information and questions, please send your inquiry to firstname.lastname@example.org